Exagen, Inc. (XGN)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
May 08, 16:00
2.96
+0.01
(+0.34%)
After-Hours: 20:00
Exagen Total Liabilities (Quarterly) : 41.75M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Veracyte, Inc. | 91.99M |
| Insight Molecular Diagnostics, Inc. | 57.22M |
| bioAffinity Technologies, Inc. | 4.284M |
| GRAIL, Inc. | 302.79M |
| FONAR Corp. | 54.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.20M |
| Shareholders Equity (Quarterly) | 17.45M |
| Debt to Equity Ratio | 1.586 |
| Current Ratio | 3.453 |
| Net Debt Paydown Yield | -0.59% |